Risk factors for liposomal bupivacaine resistance after total hip or knee arthroplasties: a retrospective observational cohort in 237 patients
- PMID: 32015758
- PMCID: PMC6990520
- DOI: 10.1186/s13037-020-0230-4
Risk factors for liposomal bupivacaine resistance after total hip or knee arthroplasties: a retrospective observational cohort in 237 patients
Abstract
Purpose: Liposomal bupivacaine demonstrated promise decreasing postoperative pain in total hip and total knee arthroplasty (THA/TKA). Some randomized trials have shown non-superior results; however, confounding variables were not accounted for in such analyses. This study attempts to determine risk factors associated with failure of pain management in patients receiving liposomal bupivacaine.
Methods: Postoperative pain scores were collected following primary or revision arthroplasties between January 2016 and December 2017. Retrospective analysis of institutional total joint quality and outcomes registry was screened and patients undergoing primary or revision arthroplasties who completed a multi-modal pain management including liposomal bupivacaine were included in the study. Patients with a history of infection/deviated from the institutional pain management protocol were excluded.
Results: A total of 237 patients were included for analysis. Younger patients less than 64 years old had significantly higher pain scores between 0 and 12 h and > 24 h. Active smokers had significantly higher pain scores between 0 and 6 h and > 24 h. Patients with a history of opioid use/pain management had significantly higher pain scores at 6-12 h and 24-48 h. Regression analysis indicated risk factors for resistance to liposomal bupivacaine are younger patients less than 64 years old, those undergoing primary THA, and patients with a history of smoking/pain management/opioid use.
Conclusion: We identify risk factors for resistance to liposomal bupivacaine, which include younger age less than 64 years old, history of smoking/pain management/opioid use. Future studies should use these risk factors as exclusion criteria when using liposomal bupivacaine or initiating any randomized trials regarding efficacy.
Keywords: Liposomal bupivacaine; Pain management; Total hip arthroplasty; Total knee arthroplasty.
© The Author(s). 2020.
Conflict of interest statement
Competing interestsThe authors declare that they have no competing interests.
Similar articles
-
The role for high volume local infiltration analgesia with liposomal bupivacaine in total hip arthroplasty: A scoping review.Orthop Rev (Pavia). 2022 Aug 5;14(3):37101. doi: 10.52965/001c.37101. eCollection 2022. Orthop Rev (Pavia). 2022. PMID: 35936804 Free PMC article.
-
Migration of Hospital Total Hip and Knee Arthroplasty Procedures to an Ambulatory Surgery Center Setting and Postsurgical Opioid Use: A Private Practice Experience.Am Health Drug Benefits. 2022 Mar;15(1):21-29. Am Health Drug Benefits. 2022. PMID: 35586615 Free PMC article.
-
Impact of liposomal bupivacaine administration on postoperative pain in patients undergoing total knee replacement.Pharmacotherapy. 2015 May;35(5):477-81. doi: 10.1002/phar.1587. Epub 2015 May 4. Pharmacotherapy. 2015. PMID: 25940854
-
Pain Control and Functional Milestones in Total Knee Arthroplasty: Liposomal Bupivacaine versus Femoral Nerve Block.Clin Orthop Relat Res. 2017 Jan;475(1):110-117. doi: 10.1007/s11999-016-4740-4. Clin Orthop Relat Res. 2017. PMID: 26883652 Free PMC article.
-
Role of Periarticular Liposomal Bupivacaine Infiltration in Patients Undergoing Total Knee Arthroplasty-A Meta-analysis of Comparative Trials.J Arthroplasty. 2017 Feb;32(2):675-688.e1. doi: 10.1016/j.arth.2016.09.042. Epub 2016 Oct 8. J Arthroplasty. 2017. PMID: 28029532 Review.
Cited by
-
The role for high volume local infiltration analgesia with liposomal bupivacaine in total hip arthroplasty: A scoping review.Orthop Rev (Pavia). 2022 Aug 5;14(3):37101. doi: 10.52965/001c.37101. eCollection 2022. Orthop Rev (Pavia). 2022. PMID: 35936804 Free PMC article.
-
Consensus statement on smoking cessation in patients with pain.J Anesth. 2022 Dec;36(6):671-687. doi: 10.1007/s00540-022-03097-w. Epub 2022 Sep 7. J Anesth. 2022. PMID: 36069935 Free PMC article. Review.
-
A practical guide for perioperative smoking cessation.J Anesth. 2022 Oct;36(5):583-605. doi: 10.1007/s00540-022-03080-5. Epub 2022 Aug 1. J Anesth. 2022. PMID: 35913572 Review.
-
Influence of smoking and socioeconomic status on labor analgesia: a nationwide register-based study in Finland.Arch Gynecol Obstet. 2024 Oct;310(4):1989-1996. doi: 10.1007/s00404-024-07647-3. Epub 2024 Jul 19. Arch Gynecol Obstet. 2024. PMID: 39028434 Free PMC article.
References
LinkOut - more resources
Full Text Sources